Ex Vivo Drug Testing in Patient-derived Papillary Renal Cancer Cells Reveals EGFR and the BCL2 Family as Therapeutic Targets

Silvia Angori; Amir Banaei-Esfahani; Katharina Mühlbauer; Hella A. Bolck; Abdullah Kahraman; Tulay Karakulak; Cedric Poyet; Michaela Feodoroff; Swapnil Potdar; Olli Kallioniemi; Vilja Pietiainen; Peter Schraml; Holger Moch

doi:10.1016/j.euf.2023.03.005

Ex Vivo Drug Testing in Patient-derived Papillary Renal Cancer Cells Reveals EGFR and the BCL2 Family as Therapeutic Targets

Silvia Angori, Amir Banaei-Esfahani, Katharina Mühlbauer, Hella A. Bolck, Abdullah Kahraman, Tulay Karakulak, Cedric Poyet, Michaela Feodoroff, Swapnil Potdar, Olli Kallioniemi, Vilja Pietiainen, Peter Schraml, Holger Moch

Research output: Conference materials › Paper › peer-review

Original language	English
Pages	751-759
Number of pages	9
DOIs	https://doi.org/10.1016/j.euf.2023.03.005
Publication status	Published - Sept 2023
MoE publication type	Not Eligible

Fields of Science

Drug sensitivity profiling
Functional precision medicine
Papillary renal cell carcinoma
Patient-derived cells
Tumour heterogeneity
3126 Surgery, anesthesiology, intensive care, radiology

Access to Document

10.1016/j.euf.2023.03.005

PIIS2405456923000676Final published version, 1.76 MBLicence: CC BY-NC-ND

Cite this

Angori, S., Banaei-Esfahani, A., Mühlbauer, K., Bolck, H. A., Kahraman, A., Karakulak, T., Poyet, C., Feodoroff, M., Potdar, S., Kallioniemi, O., Pietiainen, V., Schraml, P., & Moch, H. (2023). Ex Vivo Drug Testing in Patient-derived Papillary Renal Cancer Cells Reveals EGFR and the BCL2 Family as Therapeutic Targets. 751-759. https://doi.org/10.1016/j.euf.2023.03.005

@conference{e0b34ee65dcd458889948866c9f21551,

title = "Ex Vivo Drug Testing in Patient-derived Papillary Renal Cancer Cells Reveals EGFR and the BCL2 Family as Therapeutic Targets",

keywords = "Drug sensitivity profiling, Functional precision medicine, Papillary renal cell carcinoma, Patient-derived cells, Tumour heterogeneity, 3126 Surgery, anesthesiology, intensive care, radiology",

author = "Silvia Angori and Amir Banaei-Esfahani and Katharina M{\"u}hlbauer and Bolck, {Hella A.} and Abdullah Kahraman and Tulay Karakulak and Cedric Poyet and Michaela Feodoroff and Swapnil Potdar and Olli Kallioniemi and Vilja Pietiainen and Peter Schraml and Holger Moch",

year = "2023",

month = sep,

doi = "10.1016/j.euf.2023.03.005",

language = "English",

pages = "751--759",

}

TY - CONF

T1 - Ex Vivo Drug Testing in Patient-derived Papillary Renal Cancer Cells Reveals EGFR and the BCL2 Family as Therapeutic Targets

AU - Angori, Silvia

AU - Banaei-Esfahani, Amir

AU - Mühlbauer, Katharina

AU - Bolck, Hella A.

AU - Kahraman, Abdullah

AU - Karakulak, Tulay

AU - Poyet, Cedric

AU - Feodoroff, Michaela

AU - Potdar, Swapnil

AU - Kallioniemi, Olli

AU - Pietiainen, Vilja

AU - Schraml, Peter

AU - Moch, Holger

PY - 2023/9

Y1 - 2023/9

KW - Drug sensitivity profiling

KW - Functional precision medicine

KW - Papillary renal cell carcinoma

KW - Patient-derived cells

KW - Tumour heterogeneity

KW - 3126 Surgery, anesthesiology, intensive care, radiology

U2 - 10.1016/j.euf.2023.03.005

DO - 10.1016/j.euf.2023.03.005

M3 - Paper

C2 - 36933996

SP - 751

EP - 759

ER -